According to a new report from Intel Market Research, the global Cabozantinib Drugs market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.85 billion by 2034, growing at a steady CAGR of 7.3% during the forecast period (2025-2034). This expansion reflects increasing clinical adoption for renal cell carcinoma and hepatocellular...
English
Indonesia
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek